Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Corrigendum to "Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women" [Contraception 99 (2019) 199-204].

Heffron R, Achilles SL, Dorflinger LJ, Hapgood JP, Kiarie J, Polis CB, Steyn PS.

Contraception. 2019 Jul;100(1):88. doi: 10.1016/j.contraception.2019.05.014. No abstract available.

PMID:
31229224
2.

Planning for Outcomes (P4O) Modeling Tool: Estimating the Impact of Changing the Proportion of Injectable Progestins in the Contraceptive Method Mix.

Lebetkin E, Gao X, Taylor D, Maldonado LY, Saad A, Steiner MJ, Dorflinger LJ, Nanda K, Mastro TD.

Glob Health Sci Pract. 2019 Jun 27;7(2):317-328. doi: 10.9745/GHSP-D-19-00062. Print 2019 Jun.

3.

Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.

Heffron R, Achilles SL, Dorflinger LJ, Hapgood JP, Kiarie J, Polis CB, Steyn PS.

Contraception. 2019 Apr;99(4):199-204. doi: 10.1016/j.contraception.2018.12.001. Epub 2018 Dec 18. Erratum in: Contraception. 2019 Jul;100(1):88.

4.

In vivo release of levonorgestrel from Sino-implant (II) — an innovative comparison of explant data.

Callahan RL, Taylor D, Jenkins DW, Owen DH, Cheng L, Cancel AM, Dorflinger LJ, Steiner MJ.

Contraception. 2015 Oct;92(4):350-5. doi: 10.1016/j.contraception.2015.06.028. Epub 2015 Jul 2.

5.

Towards the development of a longer-acting injectable contraceptive: past research and current trends.

Halpern V, Stalter RM, Owen DH, Dorflinger LJ, Lendvay A, Rademacher KH.

Contraception. 2015 Jul;92(1):3-9. doi: 10.1016/j.contraception.2015.02.014. Epub 2015 Mar 4. Review.

6.

Pharmacokinetics of subcutaneous depot medroxyprogesterone acetate injected in the upper arm.

Halpern V, Combes SL, Dorflinger LJ, Weiner DH, Archer DF.

Contraception. 2014 Jan;89(1):31-5. doi: 10.1016/j.contraception.2013.07.002. Epub 2013 Jul 12.

PMID:
23993431
7.

New developments in contraception for US women.

Dorflinger LJ.

Contraception. 2013 Mar;87(3):343-6. doi: 10.1016/j.contraception.2012.12.013. Epub 2013 Jan 10. No abstract available.

PMID:
23380049
8.

Delivery of a healthy baby after first-trimester maternal exposure to lapatinib.

Kelly H, Graham M, Humes E, Dorflinger LJ, Boggess KA, O'Neil BH, Harris J, Spector NL, Dees EC.

Clin Breast Cancer. 2006 Oct;7(4):339-41.

PMID:
17092403
9.

Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial.

Steiner MJ, Dominik R, Rountree RW, Nanda K, Dorflinger LJ.

Obstet Gynecol. 2003 Mar;101(3):539-47. Erratum in: Obstet Gynecol. 2003 May;101(5 Pt 1):1026.

PMID:
12636960
10.

Metabolic effects of implantable steroid contraceptives for women.

Dorflinger LJ.

Contraception. 2002 Jan;65(1):47-62. Review.

PMID:
11861055
11.
12.

Adenosine inhibits prolactin and growth hormone secretion in a clonal pituitary cell line.

Dorflinger LJ, Schonbrunn A.

Endocrinology. 1985 Dec;117(6):2330-8.

PMID:
2998734
14.

Relative potency of progestins used in oral contraceptives.

Dorflinger LJ.

Contraception. 1985 Jun;31(6):557-70. Review.

PMID:
3899503
15.

Mechanisms of somatostatin action in pituitary cells.

Schonbrunn A, Dorflinger LJ, Koch BD.

Adv Exp Med Biol. 1985;188:305-24.

PMID:
2863938
16.

Prostaglandin F2 alpha inhibits luteinizing hormone (LH)-induced increase in LH receptor binding to isolated rat luteal cells.

Luborsky JL, Dorflinger LJ, Wright K, Behrman HR.

Endocrinology. 1984 Dec;115(6):2210-6.

PMID:
6094153
17.

Calcium is an inhibitor of luteinizing hormone-sensitive adenylate cyclase in the luteal cell.

Dorflinger LJ, Albert PJ, Williams AT, Behrman HR.

Endocrinology. 1984 Apr;114(4):1208-15.

PMID:
6323134
18.

Inhibitory characteristics of prostaglandin F2 alpha in the rat luteal cell.

Dorflinger LJ, Luborsky JL, Gore SD, Behrman HR.

Mol Cell Endocrinol. 1983 Dec;33(2-3):225-41.

PMID:
6197325
19.
20.
21.

Paracrine regulation of the corpus luteum by purines, prostaglandin and peptides.

Behrman HR, Hall AK, Gore SD, Dorflinger LJ, Luborsky JL, Polan ML.

Prog Clin Biol Res. 1982;112 Pt A:221-38. No abstract available.

PMID:
6298825
22.

Effect of cholera toxin, LH and PGF2 alpha on steroidogenesis in luteal cells.

Dorflinger LJ, Behrman HR.

Adv Exp Med Biol. 1979;112:603-11. No abstract available.

PMID:
223399
23.

Mechanisms of PGF2 alpha action in functional luteolysis.

Behrman HR, Luborsky-Moore JL, Pang CY, Wright K, Dorflinger LJ.

Adv Exp Med Biol. 1979;112:557-75.

PMID:
223398
24.

Mechanism of the rapid antigonadotropic action of prostaglandins in cultured luteal cells.

Thomas JP, Dorflinger LJ, Behrman HR.

Proc Natl Acad Sci U S A. 1978 Mar;75(3):1344-8.

Supplemental Content

Loading ...
Support Center